Document is current

Article History

Received: 13 February 2019

Accepted: 14 June 2019

First Online: 19 June 2019

Compliance with ethical standards

:

: Dr. Storch has received funding from the Deutsche Forschungsgemeinschaft (DFG) and the Helmholtz-Association. He received unrestricted research grants from GKC Melbourne, Pfizer, and TEVA Pharma, honoraria for presentations/lectures/consultancies or advisory boards from AbbVie, Bayer Healthcare, Bial, GKC, Grünenthal, UCB, Zambon, Ca, AbbVie, TEVA, Lundbeck, and UCB Pharma, outside the submitted work. He has served on the editorial boards of Stem Cells, Stem Cells International, Open Biotechnology Journal, and the Journal of Biological Chemistry. Dr. Rosqvist has nothing to disclose. Dr. Ebersbach reports grants from Boheringer Ingelheim Pharma, Ingelheim, Germany, during the conduct of the study; personal fees from UCB Pharma, Germany, Zambon Pharma, Germany, AbbVie Pharma, Germany, Desitin Arzneimittel, Germany, Bial Pharma, Germany, Grünenthal, Germany, Kohlhammer Verlag, Germany, Thieme Verlag, Germany, Stada Pharma, Germany, Licher GmbH, Germany, AOK Nordost, Britannia Pharma, UK, Neurocrine Inc., USA, Neuroderm Inc, Israel, outside the submitted work. Dr. Odin has received unrestricted research grants from GKC Melbourne, as well as, honoraria for presentations/lectures/consultancies or advisory boards from AbbVie, Bial, Britannia, Decitin, GKC, Grünenthal, Nordic Infucare, Stada, UCB, Zambon, outside the submitted work. He has served on the editorial board of NPJ.